SIGA Announces Award of First International Contract for Oral TPOXX® with Purchase by the Canadian Department of National Defence
03 avr. 2020 10h15 HE
|
SIGA Technologies Inc.
- Contract for up to $14.3 million for 15,325 Courses - NEW YORK, April 03, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused...
SIGA Technologies, Inc. Reports Financial Results for Fiscal Year 2019
05 mars 2020 16h05 HE
|
SIGA Technologies Inc.
- Announces Expectations for Product Delivery to BARDA -- Announces $50 Million Share Repurchase Program -- Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK, March 05, 2020 (GLOBE...
SIGA Announces Collaboration with Turnstone Biologics
02 mars 2020 16h30 HE
|
SIGA Technologies Inc.
SIGA to supply TPOXX® To Support Turnstone’s SKV Vaccinia Oncolytic Viral Immunotherapy Program NEW YORK, March 02, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a...
SIGA to Host Business Update Call on March 5, 2020 after Release of Year End Financial Results
20 févr. 2020 16h59 HE
|
SIGA Technologies Inc.
NEW YORK, Feb. 20, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that...
SIGA Announces Canadian Department of National Defence Intent to Purchase Up To 15,325 Courses of Oral TPOXX®
05 déc. 2019 12h10 HE
|
SIGA Technologies Inc.
Contract Would Represent First International Order of TPOXX Canadian Military Intends Firm Delivery of 2,500 Courses, with Additional Option Quantities of 12,825 Courses NEW YORK, Dec. 05, 2019 ...
SIGA Announces Canadian Release of the Advanced Contract Award Notice to Support Regulatory Filing for Oral TPOXX®
18 nov. 2019 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, Nov. 18, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the...
SIGA Technologies CEO to Speak at NCT Asia Conference on October 23, 2019
21 oct. 2019 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, Oct. 21, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr....
SIGA Completes Clinical Studies for IV Formulation of TPOXX®, NDA to be Submitted in 2020
03 oct. 2019 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it...
SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on October 3, 2019
26 sept. 2019 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, Sept. 26, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr....
SIGA Technologies CSO to Speak at The 13th CBRNe Protection Symposium on September 25, 2019
25 sept. 2019 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, Sept. 25, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr....